January 24, 2012

The Center for Genomic Science (CGS) of Istituto Italiano di Tecnologia (IIT@SEMM) based in Milan, Italy at the IFOM-IEO Campus has selected HighRes Biosolutions to supply a flexible NanoCell™ laboratory automation system. The NanoCell system will be installed in the Screening Unit of the Center and will be placed in a Biosafety Level 2+ (BSL2+) enclosure. It will automate genome-wide high-throughput and high-content siRNA screens to drive the collaborative research programs of the Center for Genomic Science of IIT@SEMM.

September 1, 2011

IRBM Science Park (Pomezia, Italy) has selected HighRes Biosolutions to supply a flexible NanoCell™ laboratory automation system. The NanoCell will be installed as IRBM updates its high-throughput screening infrastructure to support the Italian Chemical Collection and Screening Initiative, a collaboration with Italian state research institutions. The NanoCell system will automate biochemical and cell-based high-throughput screening (HTS) assays to support small-molecule drug discovery.

July 12, 2011

The David H. Koch Institute for Integrative Cancer Research at MIT has selected HighRes Biosolutions to implement modular and flexible automation for its newly implemented screening facility.  HighRes will provide The Koch Institute, which is revolutionizing the diagnosis, monitoring and treatment of cancer, with two screening systems that will be linked using HighRes’ patented dockable cart-based automation platform.  Investigators at the Koch Institute as well as other MIT affiliates will use the new systems for both genomic and biochemical approaches to fighting cancer with a particular interest in studying combination treatment synergies.

April 11, 2011

The Smaller Business Association of New England (SBANE) announced that HighRes Biosolutions is a finalist for the 2011 New England Innovation Awards, which are sponsored by Inc. Magazine and Mass High Tech. HighRes is one of only 20 companies out of 185 nominees throughout New England to be selected.

HighRes Biosolutions was founded six years ago with the aim of creating cutting-edge robotic systems, devices and consumables for life sciences research and drug discovery. The company has placed its patented flexible automated systems at numerous major pharmaceutical companies and academic research labs.

April 6, 2011

The Division of Cancer Epidemiology and Genetics (DCEG) of the National Cancer Institute (NCI) has selected HighRes Biosolutions to automate the organization of NCI’s library of approximately 8 million of its biological samples that are stored at -80°C. HighRes’ automation will inventory and collate the existing library to enable storage by study and material type to facilitate specimen withdrawals for research activities. Biological specimen containers will be briefly processed at -20⁰C by state-of-the-art automated vision, identification, labeling, and tube-picking systems followed by a rapid return to their normal -80°C storage environment.

March 28, 2011

HighRes Biosolutions announced today that it has been awarded a $125,000 tax incentive by The Massachusetts Life Science Center in exchange for HighRes’ pledge to create at least ten new jobs in 2011. HighRes is one of only 30 companies in the Bay State to receive such an award.

The Center’s Life Sciences Tax Incentive Program is aimed at spurring growth in the state’s medical device, pharmaceutical and biotech firms. Jobs created as a result of the incentives must be maintained at least five years.

February 9, 2011

The University of California Los Angeles (UCLA) School of Public Health and Los Alamos National Laboratory (LANL), as part of their development of the High Throughput Laboratory Network (HTLN) for infectious disease surveillance, have selected HighRes Biosolutions to automate a high-throughput extraction and screening system for their prototype laboratory, the Global Bio Lab at UCLA. This breakthrough project will culminate in a novel, fully automated system to prepare and screen thousands of specimens for the presence of infectious agents. This high-throughput robotic screening system has been designed to facilitate near real-time detection of harmful bacterial and viral pathogens that are of public health interest and have the potential for rapid and widespread dissemination. The system also arrays the nucleic acid extracts for whole-genome sequencing.

January 26, 2011

HighRes Biosolutions has announced the release of TCell, a brand new table-based automation system that’s the most advanced on the market. Everything about TCell was designed with usability in mind.

TCell features the easiest instrument access ever in a table system thanks to a unique design for the platforms on which instruments are located. Called three-axis device platforms, these platforms allow the operator to slide and rotate instruments almost completely out of the system for incredibly easy access. This makes offline operation and maintenance of devices more convenient than on any other table system.

November 15, 2010

The Albert Einstein College of Medicine's Biomarker Analytical Resource Center (BARC) has selected HighRes Biosolutions to automate their clinical sample testing. The BARC conducts a diverse array of immunoassay detection methodologies such as RIA, ELISA and LC/MS. The implementation of a HighRes NanoCell robotic platform will allow the group to rapidly perform these assays, and easily implement novel protocols as needed. These high performance capabilities will allow scientific staff to focus on protocol development reducing future costs to investigators.

August 23, 2010

HighRes Biosolutions, the leader in laboratory automation for life sciences, announced today that it is building a system for an undisclosed laboratory in Shanghai, China. The new system will be installed in the fall of 2010 by HighRes and Tekon Biotech Ltd, the Asian distributor representing HighRes in this region.